Post-Test The Psychiatry Clinician’s Role in the Management of Parkinson Disease Psychosis With or Without Dementia Post-Test Which of the following is the most common manifestation of Parkinson disease psychosis Auditory hallucinations Visual hallucinations Panic attacks Paranoid delusions Which of the following is the primary contributor to the development of Parkinson disease psychosis with or without dementia? Loss of serotonergic neurons Loss of dopaminergic neurons Use of anticholinergic medications Use of dopaminergic medications In the absence of a scale specifically designed to diagnose Parkinson disease psychosis, which of the following (in combination with a clinical diagnostic interview) would you employ as a reliable and robust method of assessment (though limited in application with patients with dementia)? Patient/care partner account Neuropsychiatric Inventory (NPI) Brief Psychiatric Rating Scale (BPRS) Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions (SAPS-H+D) When considering the pathophysiology of Parkinson disease psychosis, emphasis should be placed on using an agent with which receptor binding property? High 5-HT2A receptor affinity Potent serotonin reuptake inhibition Moderate D2 receptor partial agonism Moderate muscarinic M1 receptor antagonism Which of the following is the only medication approved by the FDA for the treatment of hallucinations and delusions associated with Parkinson disease psychosis? Clozapine Pimavanserin Quetiapine Ulotaront Please rate your ability to recognize and evaluate symptoms to assess for Parkinson disease psychosis Excellent Very Good Good Fair Poor Please rate your ability to optimize collaborative, multidisciplinary, and patient-centered treatment for Parkinson disease psychosis Excellent Very good Good Fair Poor Previous
